Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Healthcare — Hospitals & Diagnostics.”
₹1,371 Cr revenue.
COGS 26.9%, employees 18.3%.
Historical valuation data not available.
Revenue segment breakdown not available.
| (₹ Cr) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹1,371 Cr +12.4% | ₹1,220 Cr +19.7% | ₹1,019 Cr +12.4% | ₹906 Cr +31.2% | ₹690 Cr -3.0% | ₹712 Cr +13.4% | ₹628 Cr |
| Other Income | ₹22 Cr +5.5% | ₹21 Cr +22.0% | ₹17 Cr +45.2% | ₹12 Cr -0.2% | ₹12 Cr +11.9% | ₹11 Cr +28.6% | ₹8 Cr |
| Total Income | ₹1,393 Cr +12.3% | ₹1,241 Cr +19.8% | ₹1,036 Cr +12.8% | ₹918 Cr +30.7% | ₹702 Cr -2.8% | ₹722 Cr +13.6% | ₹636 Cr |
| COGS | ₹368 Cr +13.7% | ₹324 Cr +14.5% | ₹283 Cr +10.4% | ₹256 Cr +32.4% | ₹194 Cr -5.5% | ₹205 Cr +9.3% | ₹187 Cr |
| ₹1,116 Cr +11.2% | ₹1,003 Cr +13.9% | ₹881 Cr +13.3% | ₹777 Cr +30.3% | ₹596 Cr -2.3% | ₹610 Cr +12.4% | ₹543 Cr | |
| Profit Before Tax | ₹278 Cr +16.8% | ₹238 Cr +53.0% | ₹155 Cr +10.3% | ₹141 Cr +33.0% | ₹106 Cr -5.5% | ₹112 Cr +20.5% | ₹93 Cr |
| ₹69 Cr +18.6% | ₹58 Cr +46.6% | ₹39 Cr +8.3% | ₹36 Cr +29.8% | ₹28 Cr +61.9% | ₹17 Cr -47.0% | ₹33 Cr | |
| Net Profit | ₹209 Cr +16.3% | ₹180 Cr +55.3% | ₹116 Cr +11.0% | ₹104 Cr +34.2% | ₹78 Cr -17.9% | ₹95 Cr +57.3% | ₹60 Cr |
| Other Comprehensive Income | (₹0.38 Cr) ↓ Decline | ₹0.71 Cr +32.0% | ₹0.53 Cr ↑ Recovery | (₹2 Cr) ↓ Decline | ₹1 Cr +13.8% | ₹1 Cr ↑ Recovery | (₹0.25 Cr) |
| EPS | ₹190.95 | ₹164.25 | ₹105.80 | ₹95.28 | ₹71.00 | ₹86.44 | ₹54.96 |
| Diluted Shares | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Kovai Medical Center & Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve among other .... Kovai Med...
We enclose herewith the the Postal ballot Notice for seeking approval of members, to approve the Reappointment of Mr.A.P.Ammasaikutti and Dr.K.Kolandaswamy as Independent Directors of the .... We encl...
We wish to inform you that the Board of Directors at their meeting held on 06.03.2026 had approved the reappointment of Mr.A.P.Ammasaikutti and Dr.K.Kolandaswamy as Non -executive Independent .... We ...
We wish to inform you that the Board of Directors at their Board Meeting held on 06.03.2026 had inter alia approved: 1. The Reappointment of Independent Directors of the Company. 2. Approved .... We...
Kovai Medical Center & Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2026 ,inter alia, to consider and approve We hereby inform .... Kova...
We enclose the copies of Newspaper Advertisement published in English and Tamil on 07th February, 2026 in the "Trinity Mirror" and "Makkal Kural" respectively, with regard to the Financial .... We enc...
We are proud to announce the launch of "KMCH Institute of Neuro Sciences & OPD Block" and "KMCH Medical College Post graduate Institute" at KMCH campus - 99, Avanashi road, Coimbatore commencing .... ...
Kovai Medical Center & Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve the Un-audited .... Kovai ...
We wish to inform you that the Trading window for trading in Company securities shall remain closed from 01.01.2026 till the end of 48 hours after the declaration of Un-audited financial .... We wish ...
We herewith submit the status update for the Re-Logement of transfer request of Physical Shares.
We enclose herewith the copies of Newspaper Advertisement published in English and Tamil in the ''Trinity Mirror'' and ''Makkal Kural'' respectively, with regard to the special window for .... We encl...
We enclose herewith the copies of Newspaper Advertisement published in English and Tamil on 8th November 2025 with regard to Financial Results for the quarter/half year ended 30.09.2025.
Pursuant to Regulation 23(9) of SEBI(LODR) Regulations, 2015, we enclose herewith the disclosure of related party transactions for the half year ended 30.09.2025.
This is to inform you that the Board of Directors at their meeting held on 07.11.2025 had approved the Un-audited Financial Results for the Quarter/Half year ended 30.09.2025
This is to inform you that the Board of Directors at their meeting held on 07.11.2025 had approved: 1. Un-audited Standalone Financial Results of the Company for the Quarter/Half year .... This is to...
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.